Lv52
1154 积分 2025-04-03 加入
Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study
10分钟前
待确认
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
1天前
已完结
Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer
3天前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
7天前
已完结
PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
8天前
已完结
Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review
10天前
已完结
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis
11天前
已完结
Comparative efficacy of monoclonal antibodies in NMOSD: A meta-analysis of relapse prevention, disability outcomes, and safety
17天前
已完结
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
21天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
21天前
已完结